Stereotaxis Market Leadership Reinforced in Core Curriculum and Symposium Presentations at Heart Rhythm 2008

Wednesday, May 21, 2008 General News
Email Print This Page Comment bookmark
Font : A-A+

ST. LOUIS, May 20 Stereotaxis, Inc.(Nasdaq: STXS) today reported on the favorable endorsements of its Niobe(R)Magnetic Navigation System and Odyssey(TM) information management toolsreceived from key opinion leaders in electrophysiology at Heart Rhythm 2008,the Heart Rhythm Society's 29th Annual Scientific Sessions, which concluded onSaturday, May 17.

In his core curriculum presentation, Dr. Xu Chen of theRigshospitalet -- Copenhagen University Hospital, reported 100% acute successand 92% chronic success, with zero complications, in pediatricsupraventricular tachycardia cases performed with the Niobe System. Inaddition, the remote magnetic navigation system lowered his patients' meanx-ray exposure to only five minutes, which is even more important in thepediatric population to minimize the potential long-term effects of radiationon children. Dr. Chen remarked on the Niobe System's safety, pointing out howthe flexible, magnetically-guided catheter significantly reduces the risk ofperforation.

Prof. Tamas Szili-Torok of Erasmus Medical Center in Rotterdam reported ina core curriculum presentation that remote magnetic navigation is now thestandard of care for pediatric cases at Erasmus, due to its greater safety andability to navigate complex anatomy. He presented 100% acute success and 81%chronic success in pediatric supraventricular tachycardia cases with the NiobeSystem at one-year follow-up, and 92% and 75% acute and chronic success,respectively, in the even more challenging congenital heart disease cases,also at one-year follow-up. His patients experienced zero complicationsrelated to the Niobe system during these complex procedures.

In all, 90% of the 96 core curriculum sessions presented at Heart Rhythm2008, including all 33 sessions related to ablation techniques, includedpresentations delivered by physicians from institutions that have alreadypurchased or ordered a Niobe(R) Magnetic Navigation system.

Speakers at the accredited symposium, "The Integrated EP Lab: The Futureof Complex Arrhythmia Ablation," provided their perspectives on the completearray of Stereotaxis technologies, from the remote navigation of magneticcatheters to integrated information management and networking:

Dr. Andrea Natale, of the Texas Cardiac Arrhythmia Institute, endorsedmagnetic navigation as an important tool for VT mapping of the endocardium andepicardium.

Prof. Karl-Heinz Kuck of St. Georg Hospital in Hamburg, presented datademonstrating the superior tissue contact that is achievable with magneticcatheters, optimizing safety and lesion formation at low contact forces. Henoted that "it is almost impossible to perforate with a magnetic catheter."

While Prof. Carlo Pappone of San Raffaele University Hospital in Milan,Italy, using a Lasso(TM) catheter, confirmed 100% acute success in PVisolation with the magnetic irrigated catheter, the bulk of his remarksfocused on the advanced simplification, accelerated learning curve, andimproved communication that is now achievable with the Odyssey System andNetwork.

Dr. Gery Tomassoni of Central Baptist Hospital in Lexington, Kentuckyunderscored this point, suggesting that Odyssey will be the ultimate tool forthe complete integration of existing and emerging technologies in the EP Lab.

"Stereotaxis is committed to improving EP lab efficiency at every pointalong the continuum of clinical practice, from enhancing the precision,efficacy and safety of remote navigation and consolidating information andsystems management in the EP lab, to extending best practices across a growingnetwork of interconnected users," said Bevil Hogg, CEO of Stereotaxis. Mr.Hogg continued, "We were delighted with the broad spectrum of clinicalendorsements of our technology in the core curriculum, which represented theprincipal scientific content of the conference, and we were very encouraged

Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
* Your comment can be maximum of 2500 characters
I agree to the terms and conditions

News A - Z


News Search

Medindia Newsletters

Subscribe to our Free Newsletters!

Terms & Conditions and Privacy Policy.

Find a Doctor

Press Release Category

Press Release Archive

Stay Connected

  • Available on the Android Market
  • Available on the App Store